Eble JN, Sauter G., Epstein JI, Sesterhenn IA - iarc
Eble JN, Sauter G., Epstein JI, Sesterhenn IA - iarc
Eble JN, Sauter G., Epstein JI, Sesterhenn IA - iarc
You also want an ePaper? Increase the reach of your titles
YUMPU automatically turns print PDFs into web optimized ePapers that Google loves.
A<br />
B<br />
Fig. 3.87 A Malignant phyllodes tumour. High cellularity and cellular pleomorphism are obvious even at this magnification. B Leiomyosarcoma. Fascicular arrangement,<br />
high cellularity and mitotic activity are characteristic.<br />
ma. Both STUMP and stromal sarcomas<br />
characteristically express progesterone<br />
receptors (PR) and uncommonly express<br />
estrogen receptors (ER), supporting the<br />
concept that STUMP and stromal sarcomas<br />
are lesions involving hormonally<br />
responsive prostatic mesenchymal cells,<br />
the specialized prostatic stroma.<br />
STUMPS typically react positively with<br />
actin, whereas prostatic stromal sarcomas<br />
react negatively, suggesting that the<br />
expression of muscle markers in these<br />
lesions is a function of differentiation.<br />
Leiomyosarcoma<br />
Leiomyosarcomas are the most common<br />
sarcomas involving the prostate in adults<br />
{443}. The majority of patients are<br />
between 40 and 70 years of age, though<br />
in some series up to 20% of leiomyosarcomas<br />
have occurred in young adults.<br />
Leiomyosarcomas range in size between<br />
2 cm and 24 cm with a median size of 5<br />
cm. Histologically, leiomyosarcomas<br />
range from smooth muscle tumours<br />
showing moderate atypia to highly pleomorphic<br />
sarcomas. As with leiomyosarcomas<br />
found elsewhere, these tumours<br />
immunohistochemically can express<br />
cytokeratins in addition to muscle markers.<br />
There have been several well circumscribed<br />
lesions with a variable<br />
amount of nuclear atypia and scattered<br />
mitotic activity which have been referred<br />
to as atypical leiomyoma of the prostate<br />
{2233}, giant leiomyoma of the prostate<br />
{2162}, or circumscribed leiomyosarcoma<br />
of the prostate {2505}. Following<br />
either local excision or resection of prostatic<br />
leiomyosarcomas, the clinical<br />
course tends to be characterized by multiple<br />
recurrences. Metastases, when<br />
present, are usually found in the lung.<br />
The average survival with leiomyosarcoma<br />
of the prostate is between 3 and 4<br />
years. Because smooth muscle tumours<br />
of the prostate are rare, the criteria for<br />
distinguishing between leiomyosarcoma<br />
and leiomyoma with borderline features<br />
have not been elucidated. Although most<br />
"atypical leiomyomas" have shown no<br />
evidence of disease with short follow-up,<br />
a few have recurred.<br />
Rhabdomyosarcoma<br />
Rhabdomyosarcoma is the most frequent<br />
mesenchymal tumour within the prostate<br />
in childhood {1522}. Rhabdomyosarcomas<br />
of the prostate occur from<br />
infancy to early adulthood with an average<br />
age at diagnosis of 5 years. Most<br />
present with stage III disease, in which<br />
there is gross residual disease following<br />
incomplete resection or biopsy. A smaller,<br />
but significant proportion of patients<br />
present with distant metastases.<br />
Localized tumour that may be complete-<br />
A<br />
B<br />
Fig. 3.88 A Rhabdomyosarcoma. Note strap cells. B Angiosarcoma with slit-like spaces lined by atypical cells.<br />
210 Tumours of the prostate